Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III Randomized Double-blind Study to Evaluate Efficacy of Botulinum Toxin for Treating Epicondylitis

Trial Profile

A Phase III Randomized Double-blind Study to Evaluate Efficacy of Botulinum Toxin for Treating Epicondylitis

Recruiting
Phase of Trial: Phase III

Latest Information Update: 25 Sep 2018

At a glance

  • Drugs Botulinum-Toxin-A (Primary) ; Prednisolone
  • Indications Tennis elbow
  • Focus Therapeutic Use
  • Acronyms EPITOX
  • Most Recent Events

    • 14 Sep 2018 Status changed from not yet recruiting to recruiting.
    • 29 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top